Director sold ~$10.1M of Charles River Laboratories
Scheduled in advanceLoading…
CRL · NYSE · Life Sciences Tools & Services
Director sold ~$10.1M of Charles River Laboratories
Scheduled in advanceStock since the trade +2.7% · S&P 500 -0.5% · to Oct 1Traded 13 days after resultsStock within 3% of its 52-week high, after a 22% rise in the previous month
2,011 → 1,438 shares held−28% of their stake
A board member of Charles River Laboratories sold $163K of Charles River Laboratories shares. Nobody planned it ahead of time.
Officer sold ~$600K of Charles River Laboratories
Scheduled in advanceCEO sold ~$1.82M of Charles River Laboratories
Scheduled in advanceOfficer sold ~$1.04M of Charles River Laboratories
Scheduled in advanceDirector sold ~$7.9M of Charles River Laboratories
Scheduled in advanceStock since the trade +8.0% · S&P 500 -0.6% · to Oct 1Traded 1 day after resultsStock at its 52-week high, after a 31% rise in the previous month
34K → 30K shares held−12% of their stake
Charles River Laboratories's & Chief People Officer sold $1.08M of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1Traded 1 day after resultsStock at its 52-week high, after a 31% rise in the previous month
16K → 15K shares held−8% of their stake
Charles River Laboratories's SVP, Finance and CAO sold $330K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1Traded 1 day after resultsStock at its 52-week high, after a 31% rise in the previous month
14K → 13K shares held−9% of their stake
Charles River Laboratories's SVP, Finance and CAO sold $312K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1Traded 1 day after resultsStock at its 52-week high, after a 31% rise in the previous month
15K → 14K shares held−6% of their stake
Charles River Laboratories's SVP, Finance and CAO sold $235K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1Traded 1 day after resultsStock at its 52-week high, after a 31% rise in the previous month
14K → 13K shares held−6% of their stake
Charles River Laboratories's SVP, Finance and CAO sold $212K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1Traded 1 day after resultsStock at its 52-week high, after a 31% rise in the previous month
13K → 12K shares held−6% of their stake
Charles River Laboratories's SVP, Finance and CAO sold $190K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1Traded 1 day after resultsStock at its 52-week high, after a 31% rise in the previous month
13K → 12K shares held−5% of their stake
Charles River Laboratories's SVP, Finance and CAO sold $164K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1Traded 1 day after resultsStock at its 52-week high, after a 31% rise in the previous month
12K → 12K shares held−4% of their stake
Charles River Laboratories's SVP, Finance and CAO sold $128K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1Traded 1 day after resultsStock at its 52-week high, after a 31% rise in the previous month
14K → 14K shares held−3% of their stake
Charles River Laboratories's SVP, Finance and CAO sold $104K of Charles River Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +8.0% · S&P 500 -0.6% · to Oct 1Traded 1 day after resultsStock at its 52-week high, after a 31% rise in the previous month
13K → 13K shares held−2% of their stake
Charles River Laboratories's SVP, Finance and CAO sold $56K of Charles River Laboratories shares. Nobody planned it ahead of time.
Officer sold ~$1.33M of Charles River Laboratories
Scheduled in advanceDirector sold ~$16.9M of Charles River Laboratories
Scheduled in advanceStock since the trade +63.3% · S&P 500 +12.3% · to Oct 1Traded 13 days after resultsStock down 20% in the previous month
27K → 27K shares held
Charles River Laboratories's Corp Strategy & Develop spent $4.4K of their very own money to buy Charles River Laboratories shares.
Stock since the trade +77.2% · S&P 500 +18.4% · to Oct 1Traded 16 days after results
24K → 24K shares held−2% of their stake
Charles River Laboratories's Corp Strategy & Develop sold $65K of Charles River Laboratories shares. Nobody planned it ahead of time.